C&EN Whitepaper
Nitrosamine Impurities Analyses Application Guide
Brought to you by Agilent Technologies

Confidently Detect Trace Nitrosamine Impurities in Pharmaceuticals.

Recent recalls for unacceptable levels of nitrosamine impurities has spurred regulatory authorities to publish analytical testing methods for increasingly stringent regulations regarding the detection and quantification of nitrosamine impurities in drug substances and products. The Nitrosamine Impurities Application Guide provides analytical details for a broad range of drugs with technologies, proven methods and resources to simplify your nitrosamine impurities analysis.

Key Objectives:
  • Understand what mutagenic impurities are and why it’s important to characterize and quantify them, even when present in trace amounts.
  • Understand the current regulatory guidelines for nitrosamines analysis in drug substance and product in Angiotensin II Receptor Blockers (sartan), ranitidine and metformin drugs
  • Learn detailed methods for the confident identification and quantification of nitrosamines in APIs and drugs

Brought to you by:
Agilent Technologies
Please complete the form to download the whitepaper.

Agilent wants to keep in touch with you. Please let us know your preference.

By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) via email, in accordance with the ACS Privacy Policy .

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy